WHY VITAMIN A
Vitamin A deficiency is a public health problem all around the world, affecting more than 100 countries. A lack of vitamin A weakens the immune system, putting a child at greater risk of disease and early death; and it is also the leading cause of preventable child blindness.
The solution for correcting vitamin A deficiency lies in improving the child’s diet – through increased consumption of vitamin A-rich foods, naturally rich or commercially fortified foods such as processed oils or sugar.
In countries where this remains a public health problem, and while food-based solutions are gradually being implemented and scaled-up to reach those populations, giving children two doses of vitamin A per year – when children are between the ages of 6 months and 5 years of age – reduces their chance of dying by up to 24 per cent and reduces child blindness by up to 70 per cent.
MI is committed to supporting vitamin A supplement programs for children 6 to 59 months of age as one the most cost-effective ways to improve child survival.
One vitamin A capsule costs only two cents to manufacture and can often be delivered through existing child health programs, such as immunization.
Did you know?
- Vitamin A can be found in two categories of food sources: animal sources such as dairy, fish, and meat; and plant sources such as green leafy vegetables, carrots, sweet potatoes, mangos.
- Since 1997, MI has provided more than 8 billion doses of vitamin A to the world’s most vulnerable.
- According to the latest estimates by UNICEF (*State of the World’s Children 2014), global two-dose coverage of preschool age children reached 70% in 2012.
- In 2013, through the efforts of MI and partners, we reach 146 million children with 2 doses of live-saving vitamin A to boost their immunity and help protect them from preventable childhood diseases.
- MI’s vitamin A supplementation programs are in over 70 countries.
- MI provides more than 75% of the vitamin A required in developing countries.
- Since 1997, MI has provided more than 8 billion doses of vitamin A to the world’s most vulnerable. In just over 15 years, with funding from Canada’s Department of Foreign Affairs, Trade and Development Canada (DFATD), these efforts have succeeded in reaching more than 75 per cent of those who need the supplement globally.
- Today, you can find bottles of vitamin A capsules, most stamped with a Canadian flag and an MI logo, on the shelves of health posts and health centers from Afghanistan to Zimbabwe.
- In 2013 alone, MI donated enough vitamin A capsules through UNICEF to meet the needs of 146 million children in over 70 countries.
How we deliver over 8 billion capsules
Working with private sector manufacturers, originally only in Canada and now around the world, MI and UNICEF work to ensure the capsules produced can survive transport to hot climates, have a shelf life of three years, and be easily and safely administered by front-line health workers.
High doses of vitamin A in oil is encapsulated into either a red or blue gelatin capsule: blue is the lower dose, 100,000 IU, for children 6 to 11 months of age and red is the higher dose, 200,000 IU for the children 12 to 59 months. The colour of the capsule tells the health worker the dose so all they have to do is snip off the end and squeeze the contents into a child’s mouth.
Health systems support
In addition to the capsule donation program, MI works closely with UNICEF, Helen Keller International (HKI), and other development partners to support ministries of health to deliver vitamin A supplementation programs to their preschool age children. This includes:
- Working with governments to ensure vitamin A supplementation is an integral part of their child survival strategy.
- Working with ministries of health to ensure that vitamin A supplementation is part of the health package delivered at child health events, and routine contact.
- Developing tools to help health workers plan, carry out and monitor their vitamin A supplementation efforts. See, for example, MI’s Vitamin A in Child Health Weeks: A toolkit for Planning Implementing and Monitoring.
- Developing and testing models to overcome social, economic and geographic barriers that prevent children from getting vitamin A supplements.
Global Alliance for Vitamin A
MI belongs to the Global Alliance for Vitamin A (GAVA), which is an informal alliance of partners committed to reducing vitamin A deficiency by improving and sustaining high coverage of vitamin A globally to maximize its impact on child survival.
Members of GAVA include:
- Centre for Disease Control (CDC)
- Canada’s Department of Foreign Affairs Trade and Development (DFATD)
- Helen Keller International (HKI)
- United Nations Children’s Fund (UNICEF)
- United States Agency for International Development (USAID)
- World Health Organization (WHO)
Membership also included the former A2Z: the USAID Micronutrient and Child Blindness Project, which is currently represented through continued participation from Johns Hopkins University.
MI provides office space and resources to the GAVA coordinator, in addition to its ongoing technical and strategic contributions to the partnership.
Did you know?
Over 20 years ago, researchers at the University of Toronto and others compiled evidence from clinical trials around the world that showed that supplementing deficient children with vitamin A could reduce deaths in children between the ages of 6 and 59 months of age by 23 per cent. Since then, MI has been working with ministries of health, and the agencies that support them, around the world to deliver twice-yearly doses of vitamin A to deficient children in developing nations.
By the late 1990’s, life-saving vitamin A supplementation programs were scaling up at a rapid pace, but the availability of high quality vitamin A capsules became a limiting factor in many countries. To address this gap, through support by the Canadian government, MI established a global capsule donation program in collaboration with UNICEF to procure and supply high-quality vitamin A capsules to over 70 eligible countries around the world.